Finding the right treatment for patients is essential for saving lives, with some patients reacting differently to drugs and treatments than others with the same health issues. Whilst the analysis of medical data and advice from experts can help healthcare workers pinpoint personalized treatments, accessing such resources is difficult for most biopharma companies and treatment providers.
Owkin provides AI-driven precision medicine services for biopharma companies and treatment providers, leveraging AI to analyze medical data at scale to create interpretable AI assistants for the answering of research questions. These AI assistants are complemented by insights from worldwide and in-house medical experts to inform personalized treatments, novel drug discoveries, and healthcare collaboration.
Whilst the application of AI to medical data analysis is becoming increasingly common in the healthcare industry, Owkin stands out with its approach to designing bespoke AI research assistants driven by human expertise. Through this method, the company claims it can make large datasets of medical records more accessible and interpretable, facilitating personalized medical treatments, medical knowledge collaboration, and novel drug discovery.
Kirsty
Company Specialist at Welcome to the Jungle